dr menon said that CTIX would apply to the fda for both orphan and breakthrough status for kevetrin for treating rintinoblastoma. that cancer afflicts approx 264 babies every year. the treatment now is removal of the eyeball.
last jun 2013 in a PR leo stated he was thinking of taking kevetrin to europe we now see that he has with the u of bologna. that trial for aml leukemia will be done in many different european settings at the same time. kevetrin will be escalated during this trial.
seems to me there is nothing but good news near term. boo hoo for the flippers
Market Data 
Markets 
AI
